+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Lifestyle Drugs Market by Indication, Distribution Channel, Dosage Form, Route of Administration, End User, Therapeutic Class - Global Forecast to 2030- Product Image
Lifestyle Drugs Market by Indication, Distribution Channel, Dosage Form, Route of Administration, End User, Therapeutic Class - Global Forecast to 2030- Product Image
Sale

Lifestyle Drugs Market by Indication, Distribution Channel, Dosage Form, Route of Administration, End User, Therapeutic Class - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5305529
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The lifestyle drugs market is advancing as demand rises for therapies that address quality of life concerns. Senior decision-makers are navigating evolving patient preferences, technological innovation, and increasingly complex supply chains in this dynamic sector.

Market Snapshot: Lifestyle Drugs Market Size and Growth

The Lifestyle Drugs Market grew from USD 22.14 billion in 2024 to USD 23.49 billion in 2025. It is expected to continue growing at a CAGR of 5.85%, reaching USD 31.14 billion by 2030.

Scope & Segmentation: Analyzing Market Structure

  • Therapeutic Indications: Cosmetic skin treatment, erectile dysfunction, hair loss, smoking cessation, and weight loss therapies offer diverse opportunities fueled by personalized medicine and shifting consumer needs.
  • Distribution Channels: Drug stores, hospital pharmacies (private and public), online pharmacies (over the counter and prescription), and retail pharmacies (chain and independent) all create varied market access points and omnichannel strategies.
  • Dosage Forms: Capsules (hard and soft), tablets (immediate release and sustained release), creams, gels, injectables, and sprays support customized delivery aligned with patient preference and adherence requirements.
  • Routes of Administration: Oral, parenteral, topical, and inhalation modalities ensure flexibility for both chronic and acute lifestyle indications.
  • End Users: Key demand originates from clinics, hospitals, home healthcare providers, and retail environments, each supporting specific service models and access strategies.
  • Therapeutic Classes: The market includes antiandrogens, GLP-1 agonists, nicotinic receptor agents, PDE5 inhibitors, and retinoids, each with unique clinical and regulatory considerations.
  • Regional Coverage: The Americas (with a particular focus on the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (e.g., United Kingdom, Germany, France, Italy, Russia, countries in the Middle East and Africa), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asian countries) are all analyzed in depth to support strategic planning.
  • Leading Companies: Pfizer Inc., Eli Lilly and Company, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, AbbVie Inc., Teva Pharmaceutical Industries Ltd, and others are profiled for strategic context.

Key Takeaways for Senior Leaders

  • Personalized medicine is driving targeted therapy development, influencing product portfolios and market entry strategies.
  • Digital health platforms now facilitate remote patient monitoring, engagement, and data collection, rapidly becoming essential for product differentiation.
  • Integrated care models are emerging, embedding lifestyle therapies within chronic disease management to improve adherence and patient outcomes.
  • Regulatory frameworks are adapting, balancing faster approvals with safety oversight, and requiring new evidence-generation approaches for market success.
  • Value-based reimbursement trends emphasize the need for real-world data and risk-sharing agreements between manufacturers and payers.
  • Strategic alliances between life sciences and technology firms are essential for creating interoperable, end-to-end supply and engagement models.

Tariff Impact: 2025 US Trade Measures and Supply Chain Response

Recent tariff adjustments in the United States have increased costs for imported pharmaceutical ingredients and packaging, challenging existing cost structures and supply chains. Manufacturers are diversifying suppliers, investing in domestic production, and deploying advanced technologies such as blockchain for traceability and predictive analytics to optimize logistics. Although short-term costs have increased, these measures are expected to enhance long-term supply chain resilience and quality assurance.

Methodology & Data Sources

Primary insights were gathered from interviews with senior executives, regulatory authorities, healthcare providers, and patient advocates. Secondary research included the review of industry reports, peer-reviewed journals, clinical trial registries, and government data. Triangulation and expert validation ensured robust, unbiased data.

Lifestyle Drugs Market: Why This Report Matters

  • Enables data-driven product and portfolio decisions for evolving patient and payer needs across therapeutic classes and regions.
  • Provides critical context on competitive dynamics, regulatory trends, and supply chain resilience for strategic planning.
  • Facilitates identification of growth segments, distribution models, and innovation pathways to strengthen market position.

Conclusion

This research delivers actionable insights on innovation, market shifts, and strategic priorities in the lifestyle drugs sector. Executives and stakeholders can leverage these findings to drive growth and operational excellence amid evolving industry challenges.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lifestyle Drugs Market, by Indication
8.1. Introduction
8.2. Cosmetic Skin Treatment
8.3. Erectile Dysfunction
8.4. Hair Loss
8.5. Smoking Cessation
8.6. Weight Loss
9. Lifestyle Drugs Market, by Distribution Channel
9.1. Introduction
9.2. Drug Stores
9.3. Hospital Pharmacies
9.3.1. Private
9.3.2. Public
9.4. Online Pharmacies
9.4.1. Over the Counter
9.4.2. Prescription
9.5. Retail Pharmacies
9.5.1. Chain
9.5.2. Independent
10. Lifestyle Drugs Market, by Dosage Form
10.1. Introduction
10.2. Capsule
10.2.1. Hard
10.2.2. Soft
10.3. Cream
10.4. Gel
10.5. Injectable
10.6. Spray
10.7. Tablet
10.7.1. Immediate Release
10.7.2. Sustained Release
11. Lifestyle Drugs Market, by Route of Administration
11.1. Introduction
11.2. Inhalation
11.3. Oral
11.4. Parenteral
11.5. Topical
12. Lifestyle Drugs Market, by End User
12.1. Introduction
12.2. Clinic
12.3. Home Healthcare
12.4. Hospital
12.5. Retail
13. Lifestyle Drugs Market, by Therapeutic Class
13.1. Introduction
13.2. Antiandrogens
13.3. GLP-1 Agonists
13.4. Nicotinic Receptor Agents
13.5. PDE5 Inhibitors
13.6. Retinoids
14. Americas Lifestyle Drugs Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Lifestyle Drugs Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Lifestyle Drugs Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Eli Lilly and Company
17.3.3. Bayer AG
17.3.4. GlaxoSmithKline plc
17.3.5. F. Hoffmann-La Roche Ltd
17.3.6. Johnson & Johnson
17.3.7. Merck & Co., Inc.
17.3.8. Novo Nordisk a/S
17.3.9. AbbVie Inc.
17.3.10. Teva Pharmaceutical Industries Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. LIFESTYLE DRUGS MARKET MULTI-CURRENCY
FIGURE 2. LIFESTYLE DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. LIFESTYLE DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. LIFESTYLE DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. LIFESTYLE DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LIFESTYLE DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LIFESTYLE DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY COSMETIC SKIN TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ERECTILE DYSFUNCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HAIR LOSS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SMOKING CESSATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY WEIGHT LOSS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CHAIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HARD, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SOFT, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY INHALATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY CLINIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY ANTIANDROGENS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY GLP-1 AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY NICOTINIC RECEPTOR AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY PDE5 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL LIFESTYLE DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 58. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 59. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 60. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 61. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 62. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 63. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 64. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 66. AMERICAS LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES LIFESTYLE DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 79. CANADA LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. CANADA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. CANADA LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 82. CANADA LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 83. CANADA LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 84. CANADA LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 85. CANADA LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 86. CANADA LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 87. CANADA LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 88. CANADA LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. CANADA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 90. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 93. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 94. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 95. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 96. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 97. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 98. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 99. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. MEXICO LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 101. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 104. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 105. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA LIFESTYLE DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 136. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 141. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 142. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 146. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 147. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 149. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 150. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 151. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 154. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 157. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 158. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 160. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 161. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 162. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 163. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 164. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 165. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 166. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 167. FRANCE LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 168. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 169. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 171. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 172. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 173. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 174. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 175. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 176. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 177. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. RUSSIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 179. ITALY LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 180. ITALY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 181. ITALY LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 182. ITALY LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 183. ITALY LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 184. ITALY LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 185. ITALY LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 186. ITALY LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 187. ITALY LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 188. ITALY LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 189. ITALY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 190. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 191. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 193. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 194. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 195. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 196. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 197. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 198. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 199. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SPAIN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 201. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 202. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 204. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 205. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 206. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 207. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 208. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 209. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 210. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. UNITED ARAB EMIRATES LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 212. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 213. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 215. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 216. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 217. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 218. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 219. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 220. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 221. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. SAUDI ARABIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 223. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 224. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 226. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 227. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 228. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 229. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 230. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 231. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH AFRICA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 234. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 235. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 237. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 238. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 239. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 240. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 241. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 242. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 244. DENMARK LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 245. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 246. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 248. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 249. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 250. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 251. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 252. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 253. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 254. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. NETHERLANDS LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 256. QATAR LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 257. QATAR LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. QATAR LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 259. QATAR LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 260. QATAR LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 261. QATAR LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 262. QATAR LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 263. QATAR LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 264. QATAR LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 265. QATAR LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. QATAR LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 267. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 268. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 269. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 270. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 271. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 272. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 273. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 274. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 275. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 276. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. FINLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 278. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 279. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 281. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 282. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 283. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 284. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 285. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 286. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 287. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 288. SWEDEN LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 289. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 290. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 292. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 293. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 294. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 295. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 296. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 297. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 298. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 299. NIGERIA LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 300. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 301. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 302. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 303. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 304. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 305. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 306. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 307. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 308. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 309. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 310. EGYPT LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 311. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 312. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 313. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 314. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 315. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 316. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 317. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 318. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 319. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 320. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 321. TURKEY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 322. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 323. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 325. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 326. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 327. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 328. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 329. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 330. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 331. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. ISRAEL LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 333. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 334. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 335. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 336. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 337. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 338. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 339. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 340. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 341. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 342. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 343. NORWAY LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUTIC CLASS, 2018-2030 (USD MILLION)
TABLE 344. POLAND LIFESTYLE DRUGS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 345. POLAND LIFESTYLE DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 346. POLAND LIFESTYLE DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 347. POLAND LIFESTYLE DRUGS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 348. POLAND LIFESTYLE DRUGS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD MILLION)
TABLE 349. POLAND LIFESTYLE DRUGS MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 350. POLAND LIFESTYLE DRUGS MARKET SIZE, BY CAPSULE, 2018-2030 (USD MILLION)
TABLE 351. POLAND LIFESTYLE DRUGS MARKET SIZE, BY TABLET, 2018-2030 (USD MILLION)
TABLE 352. POLAND LIFESTYLE DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 353. POLAND LIFESTYLE DRUGS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 354. POLAND LIFESTYLE DRUGS MARKET SIZE, BY THERAPEUT

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lifestyle Drugs market report include:
  • Pfizer Inc.
  • Eli Lilly and Company
  • Bayer AG
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novo Nordisk A/S
  • AbbVie Inc.
  • Teva Pharmaceutical Industries Ltd

Table Information

Report AttributeDetails
No. of Pages199
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 23.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 31.14 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Lifestyle Drugs - Global Strategic Business Report - Product Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Polycystic Ovarian Syndrome Treatment Market by Treatment Type, Drug Class, Route of Administration, Distribution Channel, End User, Patient Type - Global Forecast to 2030 - Product Image

Polycystic Ovarian Syndrome Treatment Market by Treatment Type, Drug Class, Route of Administration, Distribution Channel, End User, Patient Type - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
Anti-Obesity Drugs Market by Product Type, Distribution Channel, End User, Dosage Form - Global Forecast to 2030 - Product Image

Anti-Obesity Drugs Market by Product Type, Distribution Channel, End User, Dosage Form - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Obesity Treatment Market Size, Share & Trends Analysis Report By Drug Class (GLP-1 Receptor Agonists, Lipase Inhibitors, Appetite Suppressants), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Obesity Treatment Market Size, Share & Trends Analysis Report By Drug Class (GLP-1 Receptor Agonists, Lipase Inhibitors, Appetite Suppressants), By Route Of Administration (Parenteral, Oral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 153 Pages
  • Global
From
U.S. Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Pain Medication, Hormone Therapy), By Drug Class (NSAIDs, Oral Contraceptive), By Route Of Administration (Oral), By Distribution Channel, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Pain Medication, Hormone Therapy), By Drug Class (NSAIDs, Oral Contraceptive), By Route Of Administration (Oral), By Distribution Channel, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • United States
From

About the Lifestyle Drugs Market

The Lifestyle Drugs market within the context of Anti-Obesity Drugs is a rapidly growing sector of the pharmaceutical industry. These drugs are designed to help individuals lose weight and maintain a healthy lifestyle. They are typically prescribed by a doctor and can be taken orally or injected. Commonly prescribed drugs include Orlistat, Phentermine, and Liraglutide. These drugs work by suppressing appetite, increasing metabolism, and reducing fat absorption. Additionally, lifestyle drugs can help reduce the risk of developing chronic diseases such as diabetes, heart disease, and stroke. The market for lifestyle drugs is expected to continue to grow as more people become aware of the health benefits associated with them. Additionally, the increasing prevalence of obesity and related health issues is likely to drive demand for these drugs. Some companies in the market include Novo Nordisk, GlaxoSmithKline, Sanofi, and Orexigen Therapeutics. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.